Results 91 to 100 of about 4,924 (178)

GM2 gangliosidosis in Saudi Arabia: Multiple mutations and considerations for future carrier screening

open access: yes, 2011
The GM2 gangliosidose, Tay-Sachs and Sandhoff diseases, are a class of lysosomal storage diseases in which relentless neuro-degeneration results in devastating neurological disability and premature death.
Mohammad Al- Owain   +17 more
core   +1 more source

Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction.

open access: yesPLoS Biology
Glycosphingolipids (GSL) are important bioactive membrane components. GSLs containing sialic acids, known as gangliosides, are highly abundant in the brain and diseases of ganglioside metabolism cause severe early-onset neurodegeneration. The ganglioside
Alex S Nicholson   +11 more
doaj   +1 more source

Two‐Year Follow‐Up Magnetic Resonance Imaging and Spectroscopy Findings and Cerebrospinal Fluid Analysis of a Dog with Sandhoff's Disease

open access: yesJournal of Veterinary Internal Medicine, 2018
A 13‐month‐old female Toy Poodle was presented for progressive ataxia and intention tremors of head movement. The diagnosis of Sandhoff's disease (GM2 gangliosidosis) was confirmed by deficient β‐N‐acetylhexosaminidase A and B activity in circulating ...
D. Ito   +7 more
doaj   +1 more source

Urine oligosaccharide tests for the diagnosis of oligosaccharidoses

open access: yesReviews in Analytical Chemistry, 2017
This review discusses the development of capillary electrophoresis with laser-induced detection and mass spectrometry techniques for the analysis of urinary oligosaccharides to screen for human oligosaccharidoses and related disorders.
Casado Mecedes   +4 more
doaj   +1 more source

ePoster

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Laboratory Diagnosis of Canine GM2-Gangliosidosis using Blood and Cerebrospinal Fluid

open access: yes, 2004
In the present study, laboratory techniques were used to diagnose canine GM2-gangliosidosis using blood and cerebrospinal fluid (CSF) that can be collected noninvasively from living individuals.
Hiroyuki Satoh   +5 more
core   +1 more source

Tay-Sachs disease: a case report

open access: yesThe Turkish Journal of Pediatrics, 1995
Tay-Sachs disease (GM2 gangliosidosis I) is an autosomal recessive lysosomal-storage disorder confined to the central nervous system, resulting from deficiency of hexosaminidase A.
A E Arisoy, S Ozden, G Ciliv, I Ozalp
doaj  

Molecular Pathogenesis and Therapeutic Approach of GM2 Gangliosidosis

open access: yesYAKUGAKU ZASSHI, 2013
Tay-Sachs and Sandhoff diseases (GM2 gangliosidoses) are autosomal recessive lysosomal storage diseases caused by gene mutations in HEXA and HEXB, each encoding human lysosomal β-hexosaminidase α-subunits and β-subunits, respectively. In Tay-Sachs disease, excessive accumulation of GM2 ganglioside (GM2), mainly in the central nervous system, is caused ...
openaire   +3 more sources

CSF N-glycan profile reveals sialylation deficiency in a patient with GM2 gangliosidosis presenting as childhood disintegrative disorder

open access: yes, 2016
Protein N-glycosylation consists in the synthesis and processing of the oligosaccharide moiety (N-glycan) linked to a protein and it serves several functions for the proper central nervous system (CNS) development and function.
Fiumara A   +7 more
core   +1 more source

Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis. [PDF]

open access: yesMol Genet Metab, 2021
Rowe OE   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy